Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma-Reference-Cited by-同舟云学术

Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma

Published:2022-08-10 Issue:6 Volume:35 Page:1993-2001
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Yoshimatsu Yuki,Noguchi Rei,Sin Yooksil,Tsuchiya Ryuto,Ono Takuya,Akiyama Taro,Sato Chiaki,Kobayashi Eisuke,Kojima Naoki,Yoshida Akihiko,Kawai Akira,Kondo Tadashi^ORCID

Funder

Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

https://link.springer.com/content/pdf/10.1007/s13577-022-00749-7.pdf

Reference26 articles.

1. WHO Classification of Tumours of Soft Tissue and Bone 2020.

2. Sanfilippo R, Miceli R, Grosso F, et al. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2011;18:720–5.

3. Look Hong NJ, Hornicek FJ, Raskin KA, et al. Prognostic factors and outcomes of patients with myxofibrosarcoma. Ann Surg Oncol. 2013;20:80–6.

4. Lee AY, Agaram NP, Qin LX, et al. Optimal percent myxoid component to predict outcome in high-grade myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Ann Surg Oncol. 2016;23:818–25.

5. Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. Surg Oncol Clin N Am. 2016;25:775–88.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1;Human Cell;2024-08-31

2. Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1;2024-04-19

3. A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models;BMC Cancer;2023-12-06

4. Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?;Cancers;2023-10-25